# Oskare Capital

> Oskare Capital is a VC fund in Paris backing Health Care and Biotechnology. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 9
- Last investment: Jan 2026
- Lead investor: 56%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/oskare-capital
- Website: https://oskarecapital.com

Oskare Capital is a venture capital firm.

## Contacts

5 contacts available for Oskare Capital. Shizune tracks 3 team members at Oskare Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/oskare-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.2M–$3.4M |
| Series A | $4.7M–$5.9M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 22% |
| Biotechnology | 2 | 22% |
| Medical | 1 | 11% |
| Wellness | 1 | 11% |
| Biopharma | 1 | 11% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 22% |
| Series A | 2 | 22% |
| Pre-Seed | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Italy | 1 | 11% |
| Denmark | 1 | 11% |
| United Kingdom | 1 | 11% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jeff Wechsler | Venture Partner | 0 | https://shizune.co/investors/profile/jeff-wechsler |
| Josh Levy | Operating Partner | 0 | https://shizune.co/investors/profile/josh-levy |
| Nicola Broughton | Co-Founder and Managing Partner | 0 | https://shizune.co/investors/profile/nicola-broughton |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $5.9M | Series A | Jan 22, 2026 |  |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $4.7M | Series A | Nov 08, 2023 |  |
| Leva Clinic | Leva Clinic offers health care services for people with chronic pain. Their medical services include back pain, cancer pain, endometriosis, facial pain, fibromyalgia, joint pain, knee pain, multiple sclerosis, sciatica, and so on. | $3.4M | Seed | Nov 04, 2022 |  |
| Leva Clinic | Leva Clinic offers health care services for people with chronic pain. Their medical services include back pain, cancer pain, endometriosis, facial pain, fibromyalgia, joint pain, knee pain, multiple sclerosis, sciatica, and so on. | $3.4M | Seed | Nov 04, 2022 |  |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $2M | Seed | Sep 20, 2022 |  |
| Herbolea Biotech | Herbolea is a biotech company envisioning the use of innovative, green technologies to obtain safe, high-quality and low-cost natural products. Herbolea’s patented Bio-refining Platform generates unique products from highly therapeutic potential botanicals in a safe, environmentally friendly, and cost-competitive way. The company has signedlicensing agreements with pharmaceutical companies in Canada, Colombia, Germany, Italy and Zimbabwe. The company has assembled a team of highly seasoned executives with a proven track record in building successful companies. | $5.8M | Series A | Oct 26, 2021 |  |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $1.2M | Seed | Mar 11, 2021 |  |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $1.8M | Seed | Nov 12, 2020 |  |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. |  | Pre-Seed |  |  |

9 of 9 investments shown.

## Co-investors
- [DSM Venturing](https://shizune.co/investors/profile/dsm-venturing) — VC Fund, 3 deals together
- [2420 Partners](https://shizune.co/investors/profile/2420-partners) — VC Fund, 2 deals together
- [The Footprint Firm](https://shizune.co/investors/profile/the-footprint-firm) — VC Fund, 2 deals together
- [Unconventional Ventures](https://shizune.co/investors/profile/unconventional-ventures-0eb1) — VC Fund, 2 deals together
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund, 2 deals together
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden-43cc) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund
- [PSV](https://shizune.co/investors/profile/preseed-innovation) — VC Fund
- [Seed Capital](https://shizune.co/investors/profile/seed-capital) — VC Fund

## Featured in investor lists
- [All VC Funds in Denmark](https://shizune.co/investors/vc-funds-denmark)
- [Biotechnology Investors in Denmark](https://shizune.co/investors/biotechnology-investors-denmark)
- [Biotechnology VC Funds in Denmark](https://shizune.co/investors/biotechnology-vc-funds-denmark)
- [Health Care Investors in Denmark](https://shizune.co/investors/health-care-investors-denmark)
- [Health Care VC Funds in Denmark](https://shizune.co/investors/health-care-vc-funds-denmark)
- [Biotech VC Funds in Denmark](https://shizune.co/investors/biotech-vc-funds-denmark)

## FAQ

### What does Oskare Capital invest in?

Oskare Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Oskare Capital's check size?

Oskare Capital typically joins rounds of $1.2M–$3.4M at Seed and $4.7M–$5.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Oskare Capital participates in.

### How do I contact Oskare Capital?

Public channels for Oskare Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Oskare Capital?

The team at Oskare Capital includes Jeff Wechsler (Venture Partner), Josh Levy (Operating Partner) and Nicola Broughton (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co